Related Experiment Videos
Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties
Chi H Trinh1, David P Smith, Arnout P Kalverda
1Astbury Centre for Structural Molecular Biology, School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Abstract:
Dissociation of human beta-2-microglobulin (beta(2)m) from the heavy chain of the class I HLA complex is a critical first step in the formation of amyloid fibrils from this protein. As a consequence of renal failure, the concentration of circulating monomeric beta(2)m increases, ultimately leading to deposition of the protein into amyloid fibrils and development of the disorder, dialysis-related amyloidosis. Here we present the crystal structure of a monomeric form of human beta(2)m determined at 1.8-A resolution that reveals remarkable structural changes relative to the HLA-bound protein. These involve the restructuring of a beta bulge that separates two short beta strands to form a new six-residue beta strand at one edge of this beta sandwich protein. These structural changes remove key features proposed to have evolved to protect beta sheet proteins from aggregation [Richardson, J. & Richardson, D. (2002) Proc. Natl. Acad. Sci. USA 99, 2754-2759] and replaces them with an aggregation-competent surface. In combination with solution studies using (1)H NMR, we show that the crystal structure presented here represents a rare species in solution that could provide important clues about the mechanism of amyloid formation from the normally highly soluble native protein.
Insights
The crystal structure of monomeric human beta-2-microglobulin (beta(2)m) reveals structural changes that promote amyloid fibril formation. This finding offers insights into dialysis-related amyloidosis, a complication of renal failure.
Area of Science:
- Biochemistry
- Structural Biology
- Medical Biochemistry
Background:
- Dialysis-related amyloidosis is caused by the accumulation of beta-2-microglobulin (beta(2)m) due to renal failure.
- Dissociation of beta(2)m from the HLA complex is the initial step in amyloid formation.
Purpose of the Study:
- To determine the crystal structure of monomeric human beta(2)m.
- To understand the structural basis of beta(2)m aggregation and amyloid formation.
Main Methods:
- X-ray crystallography at 1.8-A resolution.
- Solution studies using proton nuclear magnetic resonance ((1)H NMR).
Main Results:
- The crystal structure of monomeric beta(2)m shows significant structural alterations compared to HLA-bound beta(2)m.
- A beta bulge restructures into a new beta strand, creating an aggregation-competent surface.
- Solution studies confirm the existence of this aggregation-prone species in solution.
Conclusions:
- The identified structural changes in monomeric beta(2)m facilitate amyloid formation.
- This structure represents a key intermediate in the pathogenesis of dialysis-related amyloidosis.
- Findings provide crucial insights into the mechanism of amyloidogenesis from a normally soluble protein.